GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CES2, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, FABP3, HMGCR, IDO1, PIM1, PPARA, PTGS2, XDH |
9.21498 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9, DHFR |
8.04141 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.4528 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT |
7.13705 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CNR1, CYP1B1, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
7.13705 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AXL, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DHFR, FABP3, GSK3B, HMGCR, IDO1, IGF1R, MMP2, MMP9, PPARA, PTGS2, RORC, SRC |
7.13705 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CNR1, CYP1B1, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT, XDH |
6.86 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT |
6.85343 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CES2, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, FABP3, FABP4, HMGCR, MET, PPARA, PTGS2 |
6.6988 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AXL, CA2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MMP2, PPARA, PTGS2, RORC, SRC |
6.57688 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, AXL, CA2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MMP2, MMP9, PPARA, PTGS2, RORC, SRC, TERT |
6.45531 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CNR1, CNR2, CYP19A1, DHFR, FABP4, GSK3B, HMGCR, IDO1, IGF1R, MET, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
6.33925 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CNR1, CYP1B1, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT, XDH |
6.18373 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DHFR, FABP3, FABP4, FLT3, GSK3B, HMGCR, KDR, MET, PPARA, PTGS2, SRC, TERT, XDH |
6.18373 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, GSK3B, HMGCR, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT |
6.09062 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA7, CDC25B, CNR1, CYP19A1, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
6.01619 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA7, CDC25B, CNR1, CYP19A1, CYP1A1, CYP1B1, FABP3, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
5.92278 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, GSK3B, HMGCR, IDO1, PTGS2, XDH |
5.89465 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1B1, CYP2A13, CYP2A6 |
5.76044 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CES2, CYP19A1, CYP1A1, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, GSK3B, IDO1, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
5.75349 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, CDC25B, CYP1B1, FABP3, FLT3, HMGCR, IDO1, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, SRC, TERT, XDH |
5.74667 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CES2, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, FABP3, FABP4, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
5.71942 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AXL, CA2, CA7, CYP19A1, CYP1B1, FLT3, GSK3B, HMGCR, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
5.71942 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AXL, CA2, CA7, CYP19A1, CYP1B1, FLT3, GSK3B, HMGCR, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
5.70106 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
5.69236 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CES2, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, FABP3, FABP4, HMGCR, MET, PPARA, PTGS2 |
5.58588 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
5.5133 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CNR1, CNR2, CYP1B1, FABP4, GSK3B, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
5.40128 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, CA2, CYP1A1, CYP1B1, FABP4, KDR, MMP9, PTGS2, SRC, TERT |
5.26699 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, CNR1, CNR2 |
5.17714 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, FABP3, FLT3, HMGCR, PPARA, PTGS2, RORC, SRC |
5.1736 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DHFR, FABP3, HMGCR, KDR, PTGS2, SRC |
5.17351 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTGS2, TERT |
4.88591 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, CNR1, CNR2, CYP19A1, CYP1B1, DHFR, FABP3, FABP4, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
4.87739 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PTGS2 |
4.83267 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AXL, CNR1, CYP1B1, FABP4, FLT3, GSK3B, HMGCR, IDO1, KDR, MET, MMP12, MMP2, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
4.70042 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CES2, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, FABP3, FABP4, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
4.62783 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
4.47194 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CNR1, CNR2, CYP1A1, FABP3, FLT3, IDO1, PTGS2, RORC, SRC |
4.40525 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1B1, CYP2A6, CYP3A4, HMGCR |
4.33173 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1B1, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
4.2577 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1B1, CYP2A13, CYP2A6 |
4.20949 |
[BP] GO:0032787 |
None
|
ALOX5, CES2, CYP1A1, CYP1B1, CYP2A13, CYP2A6, FABP3, IDO1, PPARA, PTGS2 |
4.20781 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, CNR1, CNR2, DHFR, FABP3, FLT3, GSK3B, IGF1R, MMP2, PPARA, PTGS2, SRC |
4.19409 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
4.18962 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1B1, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
4.18962 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, GSK3B, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
4.15411 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, AXL, CA2, CA7, CNR1, CYP19A1, CYP1B1, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT |
4.14908 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, CA2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MMP12, MMP2, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TERT |
4.11024 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, FABP4, HMGCR, IDO1, KDR, MET, MMP12, PPARA, PTGS2 |
4.09356 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, AURKB, AXL, CNR1, CNR2, CYP19A1, CYP1B1, DHFR, FABP4, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
4.08344 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, FABP4, IDO1, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC |
4.08195 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AXL, CYP1B1, FLT3, GSK3B, HMGCR, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
4.08046 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, CNR1, CNR2, CYP19A1, CYP1B1, DHFR, FABP3, FABP4, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
4.06295 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES2, CYP1A1, CYP1B1, CYP2A13, CYP3A4, RORC |
4.03492 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, CNR1, CNR2, DHFR, FABP3, FLT3, GSK3B, IGF1R, MMP2, PPARA, PTGS2, SRC |
3.92034 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, FLT3, GSK3B, IGF1R, KDR, PIM1, SRC |
3.9179 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CNR1, CNR2, CYP1A1, CYP1B1, HMGCR, KDR, SRC |
3.91402 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.90964 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.90964 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, GSK3B, MET, MMP9, PPARA, SRC, TERT |
3.80763 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
3.79335 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTGS2, TERT |
3.78573 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR, IDO1 |
3.76563 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1B1, CYP2A13, CYP2A6, DHFR, FABP3, IDO1, PIM1, PPARA, PTGS2 |
3.75892 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, CYP3A4, DHFR, HMGCR, IDO1, PTGS2 |
3.63627 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CDC25B, FLT3, HMGCR, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, TERT |
3.63218 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AURKB, AXL, CA2, CA9, CYP1A1, CYP1B1, DHFR, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP2, MMP9, PTGS2, PTPN1, RORC, SRC, TERT |
3.57177 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, AXL, CNR1, CNR2, CYP19A1, CYP1B1, FABP4, HMGCR, IDO1, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SRC |
3.56207 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AXL, CYP1A1, CYP1B1, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP2, MMP9, PTGS2, RORC, SRC, TERT |
3.50951 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, CNR2, GSK3B, HMGCR, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
3.50951 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, CNR2, GSK3B, HMGCR, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
3.49868 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, CNR1, HMGCR, KDR, PTGS2, SRC |
3.39092 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
3.38698 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA9, CDC25B, CNR1, CYP19A1, CYP1A1, CYP1B1, DHFR, FABP4, FLT3, GSK3B, HMGCR, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TERT |
3.38698 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1B1, CYP2A13, CYP2A6, DHFR, FABP3, IDO1, PIM1, PPARA, PTGS2 |
3.36081 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1B1, CYP2A13, CYP2A6, DHFR, FABP3, IDO1, PIM1, PPARA, PTGS2 |
3.28507 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AXL, CYP1B1, FLT3, HMGCR, KDR, MET, PTGS2, PTPN1, SRC, XDH |
3.24145 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
3.24145 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SRC, TERT |
3.22281 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, AURKB, CDC25B, CNR1, CNR2, CYP1B1, DHFR, FABP4, FLT3, GSK3B, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
3.19743 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HMGCR |
3.18354 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, AURKB, CDC25B, CNR1, CNR2, DHFR, FABP4, FLT3, GSK3B, HMGCR, IGF1R, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
3.17593 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
3.15994 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SRC, TERT |
3.15597 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1B1, CYP3A4, FABP3, FABP4 |
3.12796 |
[BP] GO:0050999 |
None
|
CNR1, CNR2, DHFR, TERT |
3.11917 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, FABP4, IDO1, PPARA, PTGS2 |
3.11917 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, CA2, CA7, CNR1, CYP19A1, GSK3B, HMGCR, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT |
3.08562 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1B1, CYP2A6, CYP3A4, DHFR, IDO1 |
3.08562 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
3.0852 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
AXL, CNR1, CNR2, CYP1A1, IDO1, PTGS2, SRC |
3.08119 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AXL, CYP1A1, CYP1B1, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP2, PTGS2, RORC, SRC |
3.08119 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4 |
2.99848 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.99848 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, CDC25B, CES2, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, FABP3, FABP4, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
2.99848 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.99344 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AURKB, CNR1, CNR2, DHFR, FABP4, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
2.97918 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SRC, TERT |
2.97096 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.97096 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DHFR, HMGCR |
2.97096 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4 |
2.97096 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.97096 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
AXL, CNR1, CNR2, CYP1A1, IDO1, PTGS2, SRC |
2.93858 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AXL, CA2, CA9, CNR2, CYP1A1, CYP1B1, DHFR, GSK3B, IDO1, MMP2, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT |
2.92974 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.91852 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.90799 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, CNR1, CNR2, PTGS2 |
2.90748 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, CNR1, CNR2, PTGS2 |
2.90748 |
[BP] GO:0014070 |
response to organic cyclic compound
|
CA2, CA9, CNR1, CYP1A1, CYP1B1, DHFR, FLT3, PTGS2, RORC, SRC |
2.90048 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, AURKB, AXL, CDC25B, DHFR, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, PIM1, PTGS2, PTPN1, SRC, XDH |
2.86632 |
[BP] GO:0032768 |
None
|
CNR1, CNR2, DHFR, TERT |
2.82057 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AXL, CA2, CNR1, CYP1B1, HMGCR, IDO1, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SRC, TERT |
2.77148 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, GSK3B, IGF1R, MMP2, MMP9, PTGS2, RORC, SRC |
2.76963 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DHFR, FABP3, KDR, MMP2, PTGS2, SRC |
2.73702 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC |
2.73702 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AURKB, CYP19A1, CYP1A1, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, GSK3B, IDO1, XDH |
2.71969 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1B1, CYP3A4, HMGCR |
2.71207 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.71207 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
CNR1, CYP1B1, GSK3B, HMGCR, IDO1, MMP9, PTGS2, SRC, XDH |
2.70025 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
CNR1, CYP1B1, GSK3B, HMGCR, IDO1, MMP9, PTGS2, SRC, XDH |
2.66927 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, AXL, CA12, CA2, CA7, CNR1, FABP3, FABP4, FLT3, MET, SRC, TERT |
2.65802 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, AURKB, AXL, CDC25B, DHFR, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, PIM1, PTGS2, PTPN1, SRC, XDH |
2.64947 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AURKB, AXL, CYP1B1, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.63438 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.6115 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.6115 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, PTGS2 |
2.61056 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, GSK3B, MET, MMP9, PPARA, SRC, TERT |
2.60544 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, CA2, CA9, FABP3, FLT3, GSK3B, IGF1R, MMP2, PPARA, PTGS2, SRC |
2.59212 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.59202 |
[BP] GO:0007568 |
aging
|
AURKB, CNR1, CYP1A1, HMGCR, PTGS2, TERT |
2.578 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, GSK3B, IGF1R, PPARA, PTGS2, SRC |
2.57063 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.57043 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, CNR1, GSK3B, HMGCR, MMP12, PTGS2, PTPN1, SRC |
2.55545 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, CA2, CYP1A1, HMGCR, MMP2, PPARA, PTGS2, SRC, TERT |
2.5299 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
DHFR, GSK3B, HMGCR, IGF1R, MET, PTGS2, PTPN1, TERT, XDH |
2.52613 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, CDC25B, CES2, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, FABP3, FABP4, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
2.49571 |
[BP] GO:0010942 |
positive regulation of cell death
|
CNR1, CYP1B1, GSK3B, HMGCR, IDO1, MMP9, PTGS2, SRC, XDH |
2.47137 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.42107 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.4102 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
HMGCR, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.40197 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.36523 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.36523 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AURKB, CDC25B, DHFR, FABP3, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
2.35602 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.30566 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.28772 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, CDC25B, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
2.28457 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AURKB, CDC25B, FABP3, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
2.28457 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
CNR1, CNR2, FABP4, GSK3B, HMGCR, IGF1R, MMP9, PTGS2, PTPN1, SRC |
2.28457 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, CDC25B, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
2.28457 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.27733 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, DHFR, HMGCR |
2.27586 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, CDC25B, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
2.25317 |
[BP] GO:0019217 |
None
|
CNR1, FABP3, PPARA, PTGS2 |
2.22232 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, HMGCR |
2.2214 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, AXL, CNR1, CNR2, CYP19A1, IDO1, MMP12 |
2.2214 |
[BP] GO:0006066 |
None
|
AKR1B1, AKR1B10, CYP1B1, CYP3A4, DHFR, HMGCR |
2.2214 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, CDC25B, FABP3, FLT3, HMGCR, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.2214 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, CDC25B, FABP3, FLT3, HMGCR, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.2214 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AURKB, CYP1A1, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, GSK3B, IDO1, SRC, XDH |
2.21761 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CNR1, FABP4, IDO1, KDR, MET, PTGS2 |
2.20043 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.20043 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CNR2, CYP19A1, MMP12, PPARA |
2.19359 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, KDR, PTGS2, SRC |
2.18543 |
[BP] GO:0051341 |
None
|
CNR1, CNR2, DHFR, TERT |
2.17233 |
[BP] GO:0031349 |
positive regulation of defense response
|
CNR1, FABP4, IDO1, MMP12, MMP2, PTGS2, SRC |
2.16642 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.16642 |
[BP] GO:0046165 |
None
|
AKR1B1, CYP3A4, DHFR, HMGCR |
2.1596 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, AXL, CA2, CNR1, CYP1B1, GSK3B, HMGCR, IDO1, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SRC, TERT, XDH |
2.13052 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CDC25B, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC |
2.12596 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, DHFR, PPARA |
2.11664 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, CDC25B, FLT3, HMGCR, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.09384 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
MMP9, PTGS2, PTPN1, SRC |
2.06165 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, CDC25B, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.05623 |
[BP] GO:0032229 |
None
|
ADORA1, CNR2 |
2.05623 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.05623 |
[BP] GO:0010906 |
None
|
GSK3B, PPARA, RORC, SRC |
2.05623 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, CA2, CYP19A1, GSK3B, MMP12, PTGS2, SRC, TERT |
2.04753 |
[BP] GO:0030335 |
positive regulation of cell migration
|
IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.04753 |
[BP] GO:0032091 |
negative regulation of protein binding
|
AURKB, GSK3B, MET, PPARA |
2.0274 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, AURKB, CDC25B, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
2.02167 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AURKB, CNR1, DHFR, FABP4, GSK3B, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
2.01978 |
[BP] GO:0030198 |
extracellular matrix organization
|
CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.01978 |
[BP] GO:0043062 |
extracellular structure organization
|
CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.01621 |
[BP] GO:0034405 |
response to fluid shear stress
|
CA2, PTGS2, SRC |
2.01621 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
GSK3B, HMGCR, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
2.00685 |
[CC] GO:0005783 |
None
|
ADORA1, CA4, CES2, CYP19A1, FLT3, HMGCR, KDR, PTGS2, PTPN1, XDH |
2.1109 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.05623 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
CES2, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, FLT3, HMGCR, PTGS2, PTPN1 |
1.77552 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, CA1, CA2, CA4, CA7, CDC25B, CES2, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, FABP3, FABP4, FLT3, GSK3B, HMGCR, IDO1, KDR, MMP2, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT, XDH |
1.56577 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, AXL, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, FLT3, GSK3B, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SRC, TERT |
1.33046 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, XDH |
10.7941 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.6608 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CES2, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT, XDH |
9.97279 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, FABP3, FABP4, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
8.59226 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, IDO1, PTGS2, SRC |
7.25503 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
7.13705 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, IDO1, PTGS2, SRC |
7.13705 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.03859 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.24007 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, HMGCR, IDO1, PTGS2, XDH |
6.01619 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, HMGCR, IDO1, PTGS2, SRC, XDH |
6.00299 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP3A4 |
5.79074 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, XDH |
5.59407 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP3A4 |
5.06757 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, IDO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, TERT, XDH |
4.96991 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC |
4.7251 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP3A4, DHFR, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, PPARA, SRC |
4.72088 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, IDO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, TERT, XDH |
4.53902 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP3A4 |
4.51912 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4, PTGS2 |
4.47194 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
4.39848 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
4.07556 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.95243 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.50951 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
3.04699 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.9889 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
2.6115 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.6115 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.6115 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.58122 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC |
2.50774 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX5, IDO1, PTGS2 |
2.3718 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX5, IDO1, PTGS2 |
2.33132 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.19417 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.19417 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.05623 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC |
2.01621 |